Meeting Program
 |
To view program in "24 hour" time (international) click here. |
| Monday, February 21 | ||
|---|---|---|
| 3:00 - 7:30 PM | Registration | Chamisa Lobby |
| 6:30 - 7:30 PM | Refreshments | Chamisa Ballroom 2 |
| 7:30 - 8:30 PM |
Keynote Address Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Leroy E. Hood,
Institute for Systems Biology, USA
Systems Medicine and Emerging Technologies: Catalyzing a Transformation from Reactive to Proactive (P4) Medicine |
||
| Tuesday, February 22 | ||
| 7:00 - 8:00 AM | Breakfast | Los Vaqueros |
| 8:00 - 11:00 AM |
Cognitive and Emotional Deficits in Neurodegenerative Disorders: From Molecules to Phenotypes Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Akira Sawa,
Johns Hopkins University, USA
Molecular Link of Huntington-PDE4-DISC1: Potential Impact on Emotional and Cognitive Deficits in Huntington’s Disease |
||
|
Bart De Strooper,
Center for Human Genetics, Belgium
Link of gamma-Secretase and Neureglin-1: From Molecules to Psychiatric Phenotypes |
||
|
Tracy L. Young-Pearse,
Brigham and Women's Hospital and Harvard Medical School, USA
Bidirectional Signal Crosstalk between APP and DISC1 in Neurodevelopment and Aging |
||
|
Li-Huei Tsai,
Massachusetts Institute of Technology, USA
Epigenetics in Cognitive Performance and Alzheimer's Disease |
||
|
Short Talk(s) to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Chamisa Lobby |
| 11:15 AM- 1:00 PM | Poster Setup | Chamisa Ballroom 2 |
| 1:00 - 10:00 PM | Poster Viewing | Chamisa Ballroom 2 |
| 4:30 - 5:00 PM | Coffee Available | Chamisa Lobby |
| 5:00 - 7:00 PM |
Monitoring Neurodegenerative Disease Progression Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
David M. Holtzman,
Washington University, USA
CSF Biomarkers: Correlations with Imaging and Value in Diagnosis and Prognosis |
||
|
John Q. Trojanowski,
University of Pennsylvania, USA
Progress in AD Biomarkers from the AD Neuroimaging |
||
|
Holly Soares,
Pfizer Global Research and Development, USA
Utility of Multiplexed Panels as Screening Tools for Early Detection of Neurodegeneration |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Chamisa Ballroom 2 |
| 7:30 - 10:00 PM |
Poster Session 1 Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 2 |
| Wednesday, February 23 | ||
| 7:00 - 8:00 AM | Breakfast | Los Vaqueros |
| 8:00 - 11:00 AM |
Anatomical and Functional Basal of Dementia and Neurodegeneration Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Lennart Mucke,
University of California, San Francisco, USA
Hyperexcitability and Circuit Dysfunction in Alzheimer's Disease |
||
|
Bradley T. Hyman,
Massachusetts General Hospital, USA
Beyond Abeta and Tau: Downstream Targets in Alzheimer's Disease |
||
|
Lynn Raymond,
University of British Columbia, Canada
The Role of Excitoxicity in Neurodegeneration |
||
|
Thomas C. Südhof,
Stanford School of Medicine, USA
Synaptic Transmission and Neurodegeneration |
||
|
Short Talk(s) to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Chamisa Lobby |
| 11:00 AM- 1:00 PM | Poster Setup | Chamisa Ballroom 2 |
| 1:00 - 10:00 PM | Poster Viewing | Chamisa Ballroom 2 |
| 4:30 - 5:00 PM | Coffee Available | Chamisa Lobby |
| 5:00 - 7:00 PM |
Mitochondria and Protein Quality Control Dysfunction in Neurodegeneration Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Ming Guo,
University of California, Los Angeles, USA
Mitochondrial Fission and Fusion in Parkinson's Disease |
||
|
Richard J. Youle,
NINDS, National Institutes of Health, USA
Mitophagy in Parkinson's Disease |
||
|
Ana Maria Cuervo,
Albert Einstein College of Medicine, USA
Selective Autophagy and Neurodegeneration |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Chamisa Ballroom 2 |
| 7:30 - 10:00 PM |
Poster Session 2 Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 2 |
| Thursday, February 24 | ||
| 7:00 - 8:00 AM | Breakfast | Los Vaqueros |
| 8:00 - 11:00 AM |
Neurodegeneration Due to RNA and DNA Regulatory Proteins Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Virginia M.-Y. Lee,
University of Pennsylvania School of Medicine, USA
TDP-43 Proteinopathies |
||
|
Don W. Cleveland,
University of California, San Diego, USA
Rethinking ALS: What's All the FUS? |
||
|
Aaron D. Gitler,
University of Pennsylvania, USA
Novel RNA Binding Proteins in ALS |
||
|
Ted M. Dawson,
Johns Hopkins School of Medicine, USA
The Role of RNA and DNA Binding Proteins in Parkinson's Disease |
||
|
Short Talk(s) to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Chamisa Lobby |
| 11:00 AM- 1:00 PM | Poster Setup | Chamisa Ballroom 2 |
| 1:00 - 10:00 PM | Poster Viewing | Chamisa Ballroom 2 |
| 4:30 - 5:00 PM | Coffee Available | Chamisa Lobby |
| 5:00 - 7:00 PM |
Bridging Biology to Therapeutics in Neurodegenerative Disorders Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Menelas N. Pangalos,
AstraZeneca, UK
Beyond Abeta Based Therapies: Developing Novel Modulators of Synaptic Transmission |
||
|
Marc Tessier-Lavigne,
Genentech, Inc., USA
APP and DR6 in Axonal Degeneration: A Novel Therapeutic Target for Dementia |
||
|
Valina L. Dawson,
Johns Hopkins University School of Medicine, USA
Inhibitors of LRRK2 Kinase: Mechanism-Based Therapy for Parkinson's Disease |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 7:00 - 8:00 PM | Social Hour w/ Lite Bites | Chamisa Ballroom 2 |
| 7:30 - 10:00 PM |
Poster Session 3 Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 2 |
| Friday, February 25 | ||
| 7:00 - 8:00 AM | Breakfast | Los Vaqueros |
| 8:00 - 11:00 AM |
Prion and Prion-Like Contributions to Neurodegeneration Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Lary C. Walker,
Emory University, USA
Transmission of Neurodegenerative Disease by Misfolded Proteins |
||
|
Markus Tolnay,
Basel University Hospital, Switzerland
Induction and Spreading of Tau Pathology in Alzheimer's Disease |
||
|
Eliezer Masliah,
University of California, San Diego, USA
Neuron to Neuron Transmission of alpha-Synuclein |
||
|
Stephen M. Strittmatter,
Yale University, USA
Abeta Oligomers and Cellular Prion Proteins in Alzheimer's Disease |
||
|
Short Talk(s) to be Chosen from Abstracts,
|
||
| 9:20 - 9:40 AM | Coffee Break | Chamisa Lobby |
| 11:00 AM- 1:00 PM | Poster Setup | Chamisa Ballroom 2 |
| 1:00 - 10:00 PM | Poster Viewing | Chamisa Ballroom 2 |
| 4:30 - 5:00 PM | Coffee Available | Chamisa Lobby |
| 5:00 - 7:00 PM |
Inducible Pluripotent Stem Cells to Model and Treat Neurodegenerative Disorders Registered attendees for this meeting can view Abstracts for this session starting on 01/21/2011 |
Chamisa Ballroom 1 |
|
Guo-li Ming,
Johns Hopkins University, USA
Modeling Neurodegenerative and Neurodevelopment Disorders with iPS Cells |
||
|
Lorenz Studer,
Memorial Sloan Kettering Cancer Center, USA
Modeling Pathogenesis and Treatment of Familial Dysautonomic Using Patient-Specific iPSCs |
||
|
Ole Isacson,
Harvard Medical School, USA
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells |
||
|
Short Talk to be Chosen from Abstracts,
|
||
| 8:00 - 11:00 PM | Entertainment | Chamisa Ballroom 2 |
| Saturday, February 26 | ||
| Departure | ||
| *=Session Chair †=Speaker invited, not yet responded. | ||
Keystone Symposia would like to thank the sponsor of this meeting for their generous support:
We gratefully acknowledge additional support for this conference from:
|
|
We gratefully acknowledge the organizations that provide Keystone Symposia with additional support, such as marketing and advertising...
Click here to view these companies